7Baggers
 U.S. Genome Engineering Market Growth Probability, Key Vendors  openPR.com Fri, 03 Oct 2025 05:50:33 GMT
 can this beaten-down stock bounce back?  MSN Thu, 02 Oct 2025 15:51:34 GMT
 u.s. gene editing market projections 2025-2032: key trends,  openPR.com Wed, 01 Oct 2025 05:03:59 GMT
 editas medicine inc. (edit) confirms edt-401 as lead vivo program  Yahoo Finance Mon, 29 Sep 2025 04:56:25 GMT
 Why Editas Medicine Stock Was Skyrocketing This Week  MSN Sun, 28 Sep 2025 04:34:40 GMT
 genome editing market: strategic growth and investment  openPR.com Fri, 19 Sep 2025 10:07:11 GMT
 gene editing market exclusive report with detailed study &  openPR.com Wed, 17 Sep 2025 09:11:01 GMT
 why editas medicine stock was skyrocketing this week  MSN Tue, 16 Sep 2025 05:35:21 GMT
 biomedical crispr gene editing market to see booming growth  openPR.com Mon, 15 Sep 2025 12:49:14 GMT
 ieq capital llc increases stake in editas medicine, inc. $edit  MarketBeat Sat, 13 Sep 2025 03:58:58 GMT
 editas medicine bets on next-gen gene editing  Finimize Fri, 12 Sep 2025 07:00:00 GMT
 editas medicine, inc. $edit shares purchased by ieq capital llc  MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
 316,614 shares in editas medicine, inc. $edit bought by nuveen llc  MarketBeat Thu, 11 Sep 2025 18:59:29 GMT
 why is editas (edit) down 16.9% since last earnings report?  Yahoo Finance Thu, 11 Sep 2025 07:00:00 GMT
 nuveen llc makes new investment in editas medicine, inc. $edit  MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
 editas medicine q3 eps estimate increased by zacks research  MarketBeat Thu, 11 Sep 2025 00:56:06 GMT
 nuveen llc takes $367,000 position in editas medicine, inc. $edit  MarketBeat Wed, 10 Sep 2025 23:35:24 GMT
 editas medicine q3 eps forecast increased by zacks research  MarketBeat Wed, 10 Sep 2025 09:28:23 GMT
 editas medicine q3 eps estimate increased by zacks research  MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
 editas medicine bets on next-gen gene editing  Finimize Wed, 10 Sep 2025 07:00:00 GMT
 editas medicine, inc. $edit shares bought by ieq capital llc  MarketBeat Tue, 09 Sep 2025 08:45:36 GMT
 316,614 shares in editas medicine, inc. $edit bought by nuveen llc  MarketBeat Mon, 08 Sep 2025 10:08:02 GMT
 nuveen llc acquires shares of 316,614 editas medicine, inc. $edit  MarketBeat Mon, 08 Sep 2025 10:08:02 GMT
 editas medicine q3 eps estimate boosted by zacks research  MarketBeat Sun, 07 Sep 2025 11:23:41 GMT
 editas medicine q3 eps forecast boosted by zacks research  MarketBeat Sun, 07 Sep 2025 11:23:41 GMT
 brokers offer predictions for editas medicine q3 earnings  MarketBeat Sun, 07 Sep 2025 11:23:41 GMT
 why editas medicine stock was skyrocketing this week  MSN Sun, 07 Sep 2025 02:35:48 GMT
 editas medicine bets on next-gen gene editing  Finimize Sat, 06 Sep 2025 21:08:42 GMT
 h.c. wainwright reiterates buy rating on editas medicine (edit)  StreetInsider Fri, 05 Sep 2025 10:50:56 GMT
 published on: 2025-09-04 05:36:21  Newser Thu, 04 Sep 2025 10:36:21 GMT
 published on: 2025-09-04 03:48:25  Newser Thu, 04 Sep 2025 08:48:25 GMT
 editas stages comeback with hyperlipidaemia gene therapy as lead asset  FirstWord Pharma Wed, 03 Sep 2025 09:56:15 GMT
 editas medicine (edit) pt raised to $4 at wells fargo  StreetInsider Wed, 03 Sep 2025 09:03:01 GMT
 Editas Medicine at Wells Fargo Conference: Gene Editing Milestone  Investing.com Wed, 03 Sep 2025 07:00:00 GMT
 editas nominates edit-401 as lead in vivo therapy for high cholesterol  Yahoo Finance Wed, 03 Sep 2025 07:00:00 GMT
 brokerages set editas medicine, inc. (nasdaq:edit) pt at $5.10  MarketBeat Tue, 02 Sep 2025 23:08:20 GMT
 why editas medicine stock was skyrocketing this week  AOL.com Tue, 02 Sep 2025 13:39:41 GMT
 editas medicine selects edit-401 as lead in vivo development candidate  StreetInsider Tue, 02 Sep 2025 11:04:26 GMT
 can editas medicine afford to invest in growth?  AInvest Tue, 02 Sep 2025 10:21:43 GMT
 does editas medicine inc. stock have upside surprise potential  khodrobank.com Tue, 02 Sep 2025 07:27:49 GMT
 Can Editas Medicine (NASDAQ:EDIT) Afford To Invest In Growth?  Yahoo Finance Tue, 02 Sep 2025 07:00:00 GMT
 Editas Medicine nominates lead in vivo development candidate  BioWorld MedTech Tue, 02 Sep 2025 07:00:00 GMT
 editas stages comeback with hyperlipidaemia gene therapy as lead asset  FirstWord Pharma Tue, 02 Sep 2025 07:00:00 GMT
 editas medicine advances edit-401 for ldl reduction  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 editas medicine inc - nominates edit-401 as lead in vivo candidate  MarketScreener Tue, 02 Sep 2025 07:00:00 GMT
 editas medicine bets on next-gen gene editing  Finimize Tue, 02 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 11:19:56  Newser Mon, 01 Sep 2025 16:19:56 GMT
 brokerages set editas medicine, inc. (nasdaq:edit) pt at $5.10  MarketBeat Mon, 01 Sep 2025 07:26:21 GMT
 editas medicine bets on next-gen gene editing  Finimize Mon, 01 Sep 2025 07:00:00 GMT
 published on: 2025-08-30 22:58:25  Newser Sun, 31 Aug 2025 03:58:25 GMT

Editas Medicine, Inc
(NASDAQ:EDIT) 

EDIT stock logo

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. ...

Founded: 2013
Full Time Employees: 208
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends